US Bancorp
PMVP icon

US Bancorp’s PMV Pharmaceuticals PMVP Stock Holding History

US Bancorp’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-370
Closed -$1.76K – 4103
2023
Q1 		$1.76K Sell
370
-240
-39% -$1.69K ﹤0.01% 3785
2022
Q4 		$5.31K Sell
610
-443
-42% -$4.72K ﹤0.01% 3489
2022
Q3 		$13K Buy
1,053
+760
+259% +$11K ﹤0.01% 3277
2022
Q2 		$4K Sell
293
-1,723
-85% -$25.1K ﹤0.01% 3664
2022
Q1 		$42K Buy
2,016
+1,941
+2,588% +$34.2K ﹤0.01% 2711
2021
Q4 		$2K Buy
+75
New +$1.81K ﹤0.01% 3911

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

US Bancorp's PMVP Position: Q2 2023 in Review

US Bancorp sold out of PMV Pharmaceuticals (PMVP) in Q2 2023, closing a stake of 370 shares — an estimated $1.76K sold.

US Bancorp first reported a position in PMVP in Q4 2021 and held it in 6 quarters. The position peaked at $42K in Q1 2022. 106 funds tracked by Wall St. Rank hold PMVP as of Q2 2023.

  • US Bancorp reported no remaining PMV Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • US Bancorp sold 370 PMV Pharmaceuticals shares in Q2 2023, an estimated $1.76K.
  • US Bancorp first reported a position in PMV Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • US Bancorp's PMV Pharmaceuticals position peaked at $42K in Q1 2022.
  • 106 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2023.

Based on US Bancorp's 13F filing for Q2 2023, filed 10 Aug 2023.